Search research articles
Contact Us
Filters
Showing results (311-320 of 316) with videos related to
Page
of 32
Sort By:
You have reached the last page of results.
This site can display upto 316 results.
Dermatitis : Contact, Atopic, Occupational, Drug
|
November 7, 2025
<i>Letter:</i> Optimizing Dupilumab Dosing in Atopic Dermatitis: Real-World Evidence
Francesca Barei, Paolo Calzari, Stefano Macchi, et al.
International Journal of Dermatology
|
August 21, 2025
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study
Luca Potestio, Cataldo Patruno, Marika Del Gaudio, et al.
Clinical and Experimental Dermatology
|
October 30, 2025
Psoriasis and Seronegative Spondyloarthropathy in Atopic Dermatitis Patients Treated with Dupilumab or Tralokinumab: A Multicentre Observational Study
Giuseppe Lauletta, Cataldo Patruno, Luca Potestio, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 18, 2025
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study
Luigi Gargiulo, Silvia M Ferrucci, Luciano Ibba, et al.
Clinical and Experimental Dermatology
|
June 27, 2025
Clinical Course of Atopic Dermatitis after Dupilumab Discontinuation: A Multicenter Real-World Study
Francesca Barei, Stefano Macchi, Paolo Calzari, et al.
World Journal of Emergency Surgery : WJES
|
September 26, 2021
WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections
Massimo Sartelli, Federico Coccolini, Yoram Kluger, et al.
Page
of 32
Search research articles
Search
Showing results (311-320 of 316) with videos related to
Sort By:
Page
of 32
You have reached the last page of results.
This site can display upto 316 results.
Dermatitis : Contact, Atopic, Occupational, Drug
|
November 7, 2025
<i>Letter:</i> Optimizing Dupilumab Dosing in Atopic Dermatitis: Real-World Evidence
Francesca Barei, Paolo Calzari, Stefano Macchi, et al.
International Journal of Dermatology
|
August 21, 2025
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study
Luca Potestio, Cataldo Patruno, Marika Del Gaudio, et al.
Clinical and Experimental Dermatology
|
October 30, 2025
Psoriasis and Seronegative Spondyloarthropathy in Atopic Dermatitis Patients Treated with Dupilumab or Tralokinumab: A Multicentre Observational Study
Giuseppe Lauletta, Cataldo Patruno, Luca Potestio, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 18, 2025
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study
Luigi Gargiulo, Silvia M Ferrucci, Luciano Ibba, et al.
Clinical and Experimental Dermatology
|
June 27, 2025
Clinical Course of Atopic Dermatitis after Dupilumab Discontinuation: A Multicenter Real-World Study
Francesca Barei, Stefano Macchi, Paolo Calzari, et al.
World Journal of Emergency Surgery : WJES
|
September 26, 2021
WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections
Massimo Sartelli, Federico Coccolini, Yoram Kluger, et al.
Page
of 32